End-stage liver disease in persons with hemophilia and transfusion-associated infections.James J. Goedert, Angelos Hatzakis, Marilyn J. Manco‐Johnson et al.|PubMed|2002Cited by 165
Unresolved issues in prophylaxisSimon Brown, W. Schramm, Louis M. Aledort et al.|Haemophilia|2002Cited by 11
Prophylaxis re‐visited: The potential impact of novel factor and non‐factor therapies on prophylaxisManuel Carção, Thierry Lambert, Cindy Leissinger et al.|Haemophilia|2018Cited by 8
An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophiliaManuel Carção, Louis M. Aledort, Laura Avila et al.|Haemophilia|2017Cited by 6
Application of current knowledge to the management of bleeding events during immune tolerance inductionJorge Di Paola, Cindy Leissinger, Howard A. Britton et al.|Haemophilia|2006Cited by 5